I agree that this site is using cookies. You can find further informations here.
X
Miller, Alita A.
84  results:
Search for persons X
?
1

In vitro antibacterial activity of sulbactam-durlobactam in..:

McLeod, Sarah M. ; Carter, Nicole M. ; Bradford, Patricia A..
Diagnostic Microbiology and Infectious Disease.  109 (2024)  3 - p. 116344 , 2024
Link: https://doi.org/10.1016/..
 
?
2

In vitropharmacokinetics/pharmacodynamics of the β-lactamas..:

O'Donnell, John ; Tanudra, Angela ; Chen, April...
Antimicrobial Agents and Chemotherapy.  68 (2024)  1 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
3

Sulbactam-durlobactam susceptibility test method developmen..:

McLeod, Sarah M. ; Carter, Nicole M. ; Huband, Michael D....
Journal of Clinical Microbiology.  62 (2024)  1 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
4

Characterization ofAcinetobacter baumannii-calcoaceticuscom..:

Miller, Alita A. ; Moussa, Samir H. ; McLeod, Sarah M..
Antimicrobial Agents and Chemotherapy.  68 (2024)  5 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
5

Clinical Outcomes for Patients With Monomicrobial vs Polymi..:

McLeod, Sarah M ; Miller, Alita A ; Rana, Khurram...
Open Forum Infectious Diseases.  11 (2024)  4 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
6

2138. In Vitro Susceptibility of Recent Clinical Isolates o..:

McLeod, Sarah ; Carter, Nicole ; Moussa, Samir.
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
7

Molecular drivers of resistance to sulbactam-durlobactam in..:

Moussa, Samir H. ; Shapiro, Adam B. ; McLeod, Sarah M....
Antimicrobial Agents and Chemotherapy.  67 (2023)  11 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
8

Durlobactam, a Broad-Spectrum Serine β-lactamase Inhibitor,..:

Papp-Wallace, Krisztina M ; McLeod, Sarah M ; Miller, Alita A
Clinical Infectious Diseases.  76 (2023)  Supplement_2 - p. S194-S201 , 2023
Link: https://doi.org/10.1093/..
 
?
9

85. Efficacy of Sulbactam-Durlobactam (SUL-DUR) Compared to..:

Miller, Alita ; McLeod, Sarah ; Shapiro, Adam B..
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
10

225. Efficacy and safety of sulbactam-durlobactam are consi..:

Miller, Alita ; Shapiro, Adam B ; McLeod, Sarah...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
11

518. Characterization of colistin-resistant (COL-R) Acineto..:

Moussa, Samir ; McLeod, Sarah ; Miller, Alita
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
12

732. Microbiologic and clinical outcome concordance in the ..:

Altarac, David ; Miller, Alita ; McLeod, Sarah...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
13

LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/P..:

Bhavnani, Sujata M ; Bhavnani, Sujata M ; Bhavnani, Sujata M...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
14

In VitroActivity of Sulbactam-Durlobactam against Global Is..:

Karlowsky, James A. ; Hackel, Meredith A. ; McLeod, Sarah M..
Antimicrobial Agents and Chemotherapy.  66 (2022)  9 - p. , 2022
Link: https://doi.org/10.1128/..
 
?
15

734. Efficacy of sulbactam-durlobactam (SUL-DUR) versus col..:

Miller, Alita ; McLeod, Sarah ; Shapiro, Adam B...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
1-15